{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:22:02Z","timestamp":1774012922902,"version":"3.50.1"},"reference-count":30,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/mmr.2017.6507","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T10:20:10Z","timestamp":1493115610000},"page":"4338-4345","source":"Crossref","is-referenced-by-count":10,"title":["Increased CD19+CD24+CD27+ B regulatory cells are associated with insulin resistance in patients with type I Hashimoto's thyroiditis"],"prefix":"10.3892","volume":"15","author":[{"given":"Min","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changji","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"key20180110114436_b1-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-08-0797","article-title":"Studies of insulin resistance in patients with clinical and subclinical hypothyroidism","volume":"160","author":"Maratou","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key20180110114436_b2-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2006-0841","article-title":"Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects","volume":"91","author":"Fernandez-Real","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180110114436_b3-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jc.2006-1718","article-title":"Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects","volume":"92","author":"Roos","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180110114436_b4-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1210\/jc.2006-0478","article-title":"Insulin action in adipose tissue and muscle in hypothyroidism","volume":"91","author":"Dimitriadis","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180110114436_b5-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/en.2011-1793","article-title":"Thyroid hormone receptor-\u03b1 gene knockout mice are protected from diet-induced hepatic insulin resistance","volume":"153","author":"Jornayvaz","year":"2012","journal-title":"Endocrinology"},{"key":"key20180110114436_b6-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1515\/CCLM.2005.121","article-title":"Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy","volume":"43","author":"Stanick\u00e1","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"key20180110114436_b7-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1365-2265.2008.03280.x","article-title":"Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)","volume":"69","author":"Handisurya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20180110114436_b8-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/105072504323150750","article-title":"Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis","volume":"14","author":"Dessein","year":"2004","journal-title":"Thyroid"},{"key":"key20180110114436_b9-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2337\/diab.24.9.829","article-title":"Carbohydrate tolerance in autoimmune thyroiditis","volume":"24","author":"Finucane","year":"1975","journal-title":"Diabetes"},{"key":"key20180110114436_b10-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fendo.2013.00076","article-title":"Immune regulation in T1D and T2D: Prospective role of foxp3+ treg cells in disease pathogenesis and treatment","volume":"4","author":"Kornete","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20180110114436_b11-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180110114436_b12-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.1100713","article-title":"Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells","volume":"187","author":"Penaranda","year":"2011","journal-title":"J Immunol"},{"key":"key20180110114436_b13-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.clim.2009.04.007","article-title":"Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years","volume":"132","author":"Herold","year":"2009","journal-title":"Clin Immunol"},{"key":"key20180110114436_b14-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"key20180110114436_b15-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm.2353","article-title":"B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies","volume":"17","author":"Winer","year":"2011","journal-title":"Nat Med"},{"key":"key20180110114436_b16-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.humimm.2003.12.001","article-title":"Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function","volume":"65","author":"Filaci","year":"2004","journal-title":"Hum Immunol"},{"key":"key20180110114436_b17-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cmi.2012.60","article-title":"Regulatory B cells in autoimmune diseases","volume":"10","author":"Yang","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"key20180110114436_b18-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"key20180110114436_b19-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J Immunol"},{"key":"key20180110114436_b20-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"key20180110114436_b21-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40618-013-0013-1","article-title":"Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice","volume":"37","author":"Shi","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"key20180110114436_b22-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1476-5381.2010.01056.x","article-title":"Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes","volume":"162","author":"Lin","year":"2011","journal-title":"Br J Pharmacol"},{"key":"key20180110114436_b23-mmr-15-06-4338","first-page":"1047","article-title":"Thyroiditis: Differential diagnosis and management","volume":"61","author":"Slatosky","year":"2000","journal-title":"Am Fam Physician"},{"key":"key20180110114436_b24-mmr-15-06-4338","first-page":"539","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications","volume":"1","author":"Alberti","year":"1998","journal-title":"Part"},{"key":"key20180110114436_b25-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: Common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"key20180110114436_b26-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.2337\/diabetes.51.2007.S212","article-title":"Accurate assessment of beta-cell function: The hyperbolic correction","volume":"51","author":"Bergman","year":"2002","journal-title":"Diabetes"},{"key":"key20180110114436_b27-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/ATVBAHA.108.165100","article-title":"T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance","volume":"28","author":"Kintscher","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180110114436_b28-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"key20180110114436_b29-mmr-15-06-4338","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00125-010-1730-z","article-title":"Toll-like receptors regulate B cell cytokine production in patients with diabetes","volume":"53","author":"Jagannathan","year":"2010","journal-title":"Diabetologia"},{"key":"key20180110114436_b30-mmr-15-06-4338","unstructured":"DeFuriaJBelkinaACJagannathan-BogdanMSnyder-CappioneJCarrJDNersesovaYRMarkhamDStrisselKJWatkinsAAZhuMB cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profileProc Natl Acad Sci USA11051335138201310.1073\/pnas.12158401103612635"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6507\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T21:14:04Z","timestamp":1569100444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,25]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/mmr.2017.6507"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6507","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}